Literature DB >> 10607864

Effects of the 5-HT(3) receptor antagonist ondansetron on the ketamine- and dizocilpine-induced place preferences in mice.

T Suzuki1, T Aoki, H Kato, M Yamazaki, M Misawa.   

Abstract

The effects of the 5-HT(3) receptor antagonist ondansetron on the ketamine- and dizocilpine-induced place preferences in mice were examined. The non-competitive NMDA receptor antagonists ketamine (1. 0-10 mg/kg, i.p.) and dizocilpine (0.1 and 0.2 mg/kg, i.p.) each produced a place preference in a dose-dependent manner. The ketamine (10 mg/kg)- and dizocilpine (0.2 mg/kg)-induced place preferences were dose-dependently blocked by pretreatment with ondansetron (0. 03-0.1 mg/kg, s.c.). These results suggest that 5-HT(3) receptor may be involved in the development of the place preferences produced by ketamine and dizocilpine.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10607864     DOI: 10.1016/s0014-2999(99)00762-1

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  11 in total

1.  Context-Specific Tolerance and Pharmacological Changes in the Infralimbic Cortex-Nucleus Accumbens Shell Pathway Evoked by Ketamine.

Authors:  Gleice Kelli Silva-Cardoso; Manoel Jorge Nobre
Journal:  Neurochem Res       Date:  2021-03-30       Impact factor: 3.996

2.  The novel ketamine analog methoxetamine produces dissociative-like behavioral effects in rodents.

Authors:  Adam L Halberstadt; Natalia Slepak; James Hyun; Mahalah R Buell; Susan B Powell
Journal:  Psychopharmacology (Berl)       Date:  2016-01-13       Impact factor: 4.530

Review 3.  Ketamine: promising path or false prophecy in the development of novel therapeutics for mood disorders?

Authors:  Gerard Sanacora; Alan F Schatzberg
Journal:  Neuropsychopharmacology       Date:  2014-09-26       Impact factor: 7.853

4.  Rapid antidepressant effects and abuse liability of ketamine.

Authors:  Chun Yang; Kenji Hashimoto
Journal:  Psychopharmacology (Berl)       Date:  2014-03-26       Impact factor: 4.530

5.  Repeated ketamine exposure induces an enduring resilient phenotype in adolescent and adult rats.

Authors:  Eric M Parise; Lyonna F Alcantara; Brandon L Warren; Katherine N Wright; Roey Hadad; Omar K Sial; Kyle G Kroeck; Sergio D Iñiguez; Carlos A Bolaños-Guzmán
Journal:  Biol Psychiatry       Date:  2013-06-19       Impact factor: 13.382

6.  Ketamine sensitization: Influence of dose, environment, social isolation and treatment interval.

Authors:  Keith A Trujillo; Colleen Y Heller
Journal:  Behav Brain Res       Date:  2019-10-05       Impact factor: 3.332

7.  NMDA or AMPA/kainate receptor blockade prevents acquisition of conditioned place preference induced by D(2/3) dopamine receptor stimulation in rats.

Authors:  Anna-Maria Biondo; Robert L H Clements; David J Hayes; Brendan Eshpeter; Andrew J Greenshaw
Journal:  Psychopharmacology (Berl)       Date:  2005-03-03       Impact factor: 4.530

8.  Depression in chronic ketamine users: Sex differences and neural bases.

Authors:  Chiang-Shan R Li; Sheng Zhang; Chia-Chun Hung; Chun-Ming Chen; Jeng-Ren Duann; Ching-Po Lin; Tony Szu-Hsien Lee
Journal:  Psychiatry Res Neuroimaging       Date:  2017-09-05       Impact factor: 2.376

9.  A Negative Allosteric Modulator for α5 Subunit-Containing GABA Receptors Exerts a Rapid and Persistent Antidepressant-Like Action without the Side Effects of the NMDA Receptor Antagonist Ketamine in Mice.

Authors:  Panos Zanos; Mackenzie E Nelson; Jaclyn N Highland; Samuel R Krimmel; Polymnia Georgiou; Todd D Gould; Scott M Thompson
Journal:  eNeuro       Date:  2017-03-07

10.  Reduction of dopamine D2/3 receptor binding in the striatum after a single administration of esketamine, but not R-ketamine: a PET study in conscious monkeys.

Authors:  Kenji Hashimoto; Takeharu Kakiuchi; Hiroyuki Ohba; Shingo Nishiyama; Hideo Tsukada
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2016-04-18       Impact factor: 5.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.